Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | ABL1 | P00519 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 5/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 4/20 | 0.40 |
| ▸ | STAT1 | P42224 | 1/20 | 0.39 |
| ▸ | TYR | P14679 | 1/20 | 0.39 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5550188 | 1.00 | KDM4E (0.54) | KDM4EHSD17B10MAPTL3MBTL1ABL1 | |
| SCHEMBL972621 | 0.85 | KDM4E (0.52) | KDM4EHSD17B10MAPTL3MBTL1ABL1 | |
| SCHEMBL972620 | 0.85 | KDM4E (0.52) | KDM4EHSD17B10MAPTL3MBTL1ABL1 | |
| SCHEMBL3939082 | 0.85 | KDM4E (0.53) | KDM4EHSD17B10MAPTL3MBTL1ABL1 | |
| SCHEMBL3939083 | 0.85 | KDM4E (0.53) | KDM4EHSD17B10MAPTL3MBTL1ABL1 | |
| SCHEMBL3939079 | 0.85 | KDM4E (0.53) | KDM4EHSD17B10MAPTL3MBTL1ABL1 | |
| SCHEMBL971939 | 0.85 | KDM4E (0.53) | KDM4EHSD17B10MAPTL3MBTL1ABL1 | |
| SCHEMBL971938 | 0.85 | KDM4E (0.53) | KDM4EHSD17B10MAPTL3MBTL1ABL1 | |
| SCHEMBL974413 | 0.84 | KDM4E (0.56) | KDM4EHSD17B10MAPTL3MBTL1ABL1 | |
| SCHEMBL974414 | 0.84 | KDM4E (0.56) | KDM4EHSD17B10MAPTL3MBTL1ABL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070254931-A1 | Thiazole Derivatives Having Vap-1 Inhibitory Activity | ASTELLAS PHARMA INC. (JP) | 2007-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070254931-A1 | Thiazole Derivatives Having Vap-1 Inhibitory Activity | VCAM1, VAPB, VAPA | KDM4E 3784/4885HSD17B10 2150/4885MAPT 163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.